Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 27,700 | 63,230 | 0 | 42,060 | 41,390 |
| Cost of Goods | 18,700 | 16,500 | N/A | 12,930 | 11,740 |
| Gross Profit | 9,000 | 46,730 | 19,200 | 29,130 | 29,640 |
| Operating Expenses | 34,910 | 71,190 | 57,100 | 66,130 | 56,040 |
| Operating Income | -25,210 | -23,960 | -57,100 | -36,070 | -25,650 |
| Interest Expense | 20 | 5 | 0 | 80 | 1,450 |
| Other Income | 2,020 | -755 | 0 | 2,160 | 5,280 |
| Pre-tax Income | -23,210 | -24,720 | -57,100 | -33,990 | -21,820 |
| Income Tax | 0 | 0 | N/A | -1,960 | -29,120 |
| Net Income Continuous | -23,218 | -24,724 | -59,817 | -32,037 | -21,830 |
| Net Income Discontinuous | 0 | 0 | N/A | -250 | 26,090 |
| Net Income | $-23,210 | $-24,720 | $-59,817 | $-32,290 | $33,390 |
| EPS Basic Total Ops | -18,596.28 | -25,794.84 | -67,186.56 | -36,592.68 | 38,392.30 |
| EPS Basic Continuous Ops | -17,860.00 | -27,471.11 | -66,463.34 | -35,596.66 | -24,255.55 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -277.78 | 28,988.89 |
| EPS Diluted Total Ops | -18,596.28 | -25,794.84 | -67,186.56 | -36,592.68 | 38,392.30 |
| EPS Diluted Continuous Ops | -17,860.00 | -27,471.11 | -66,463.34 | -35,596.66 | -24,255.55 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -277.78 | 28,988.89 |
| EBITDA(a) | $-23,620 | $3,890 | $-49,950 | $-30,430 | $-16,230 |